0150’ we -3
WWW/W825. 852/1] 3

UUID: C6267522- --C6F2 4644- --AEAB 1F92EF1R13eB75aC
TCGA- -QV -A915- 91A- -PR

II IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIRIIIIIIIIICIIEd
IlIIIIIIIIIIIIIH I|I|||I|II|III|IIII||III IIIIIIIIIIIIIIIIIIIII
II IIIIIIIIIIIIIIIIIIIIIIIIIlIIIIIIIIIIIIIIIIIIII IIIIIIIII

Collect date:

 

PATHOLOGY REPORT:
PRIMARY SITE: Stomach (Body)

l-Greater omentum:
- Uninvolved by neoplasia.

2- Product of extended gastrectomy (stomach+spleen+pancreatic body and tail):
Gastric adenocarcinoma with the following features:

-Site: gastric cardia and body on lesser curvature.

-Largest tumor size: 1 1.0 cm.

-Ulceration: present. _ a , (1 4 Z: , .
-Histologic patterns: solid and tubular. PW Tég ' I ad 70

-Lauren classiﬁcation: intestinal type.

-Local invasion: mucosa, submucosa, muscularis propria and perivisceral fat tissue.
-Presence of neural invasion.

-Presence of lymphatic invasion.

-Blood vessel invasion: not observed.

-Spleen and pancreatic segment uninvolved by neoplasia.

-Surgical margins uninvolved by neoplasia.

-Number of lymph nodes involved by neoplasia: 2/32.

-Report of examined lymph nodes according to standardization:

Lymph nodes adjacent to specimen (labeled “D”): 1/3

Chain 1 — right paracardic (G): 0/0

Chain 2 — left paracardic (H): 0/0

Chain 3 — lesser curvature (1): U4

Chain 45b — left gastroepiploic (J): 0/2

Chain 4d — right gastroepiploic (Kl-K2): 0/6

Chain 5 — suprapyloric (L): 0/1

Chain 6 — infrapyloric (Ml—M3): 0/ 10

Chain 7a — left gastric artery (N I-N2): 0/6

Chain 8a (0): 0/3

Chain 9 — Celiac trunk (P): 0/3

Chain 1 1p - proximal splenic artery (Q): 0/4

3- Esophageal margin
Uninvolved by neoplasia.

Pw'fss 416W WW7
466.6 vlwrw “ 0“ 7°

 

 

 

 

 

 

 

 

 

. I
W A14, t/ :1/ “f '9‘ No
granolslscgsD rearivcviimlbhmw V’ \I
; Pr .man/Yumorsuie eiscD row" (\i /
on; Primary [WV I ' d

 

 

 

 

 

W / msquxmnm
Date Revwwed: .LL/ 1

 

 

W, 7
TCGA Pathologic Diagnosis Discrepancy Form ‘ n

 

 

 

 

 

 

W The TC GA Pathoiogic Diagnosis Discrepancy Form should be completed when the pathologic diagnosis
documented on the initial pathology repo rtJOr a case submitted for TCGA is inconsistent with the diagnosis provided on the
Case Quality Comm} Form completedfor the submitted case.

 

 

 

Tissue Source Site (TESS): ‘ TSS identiﬁer: _7 TSS Unique Patient Identiﬁer: H

Completed By (Intcn'ie\~JcrNairie on OpenC/inica): Completed Date: ,

 

IBiagnosis Information

 

if Data Eiement Entry Alternatives Working Instructions

Provide the diagnosis / histologic subtypeﬁ} documented on
Pzirhoiogic Diagnosis - ~ , the initial pathology report for this case. lithe histology for
1 Provided on Initiei M this case is mixed, provide all listed suhtypes.

Pathology Report

 

 

. . . Provide the histologic features selected on the TCfo Case
Histologicfeatures 03 ,, ~ . ». V,

2 the sample provided 100% "I‘ubuinr Adenoczircinoma Quality Control Form Complcted for this casL.
for TCGA, as reﬂected
on the CQCF.

 

 

EDiscrepancy between Pathology Report and Case Quality Control Form

 

 

 

 

3 Provide the reason for ‘ ‘ ‘ _ Promdc a reason describing why the diagnosis on the initial
the (I i‘iCi‘L’ 'mc Case was revwwed based on Top SI idc to be pathology report for this case is not consistent with the
b w . E36 2:1 I Quilt i!) BCR (iéagnosls seiected on Lhe TCGA {Lise Quaiity Control Form
e can map no 0g} ..
report, and the TCGA
Case Quaiity Control
Form.
Name of T53 Reviewing ‘ Swag/iii? nnme of the pathologn‘st who reviewed this case
4 Pathologist or w_ ‘3’ '
Biorepository Director

 

 

 

 

 

I acknowledge that the above information provided by my institution is true and correct and has been quaiity controlled.

 

T 33 Reviewing Pathologist or Biorepository Director Date

I acknowiedge that'zhe above information provided by my Institution is true and correct and has been quality controlled, The Attending Pathologist or the
Depormient Chairman has been informed or is aware of me above discrepancy in diagnoses.

ijrincigﬁai investigatorSignatme Date

 

 

